½ÃÀ庸°í¼­
»óǰÄÚµå
1800994

¸¶Ãë¿ë ºñµð¿À ÈÄµÎ°æ ½ÃÀå º¸°í¼­ : Á¦Ç°º°, ºí·¹À̵å À¯Çüº°, ÃÖÁ¾»ç¿ëÀÚº°, Áö¿ªº°(2025-2033³â)

Anesthesia Video Laryngoscope Market Report by Product, Blade Type, End User, and Region 2025-2033

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: IMARC | ÆäÀÌÁö Á¤º¸: ¿µ¹® 140 Pages | ¹è¼Û¾È³» : 2-3ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

¼¼°èÀÇ ¸¶Ãë¿ë ºñµð¿À ÈÄµÎ°æ ½ÃÀå ±Ô¸ð´Â 2024³â¿¡ 2¾ï 1,240¸¸ ´Þ·¯¿¡ ´ÞÇß½À´Ï´Ù. ÇâÈÄ IMARC GroupÀº ½ÃÀåÀÌ 2033³â±îÁö 3¾ï 3,780¸¸ ´Þ·¯¿¡ ´ÞÇϸç, 2025-2033³âÀÇ ¼ºÀå·ü(CAGR)Àº 5.03%¸¦ º¸ÀÏ °ÍÀ¸·Î ¿¹ÃøÇϰí ÀÖ½À´Ï´Ù. ÃÖ¼Ò Ä§½À ¼ö¼ú¿¡ ´ëÇÑ ¼ö¿ä ±ÞÁõ, Áö¼ÓÀûÀÎ ±â¼ú ¹ßÀü, ³ëÀÎ Àα¸ Áõ°¡, ÀÇ·á ÅõÀÚ Áõ°¡°¡ ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇϰí ÀÖ½À´Ï´Ù.

¸¶Ãë¿ë ºñµð¿À ÈÄµÎ°æ ½ÃÀå µ¿Çâ

Àúħ½À ¼ö¼ú Áõ°¡ Ãß¼¼

ÇコÄÉ¾î »ê¾÷Àº ÃÖ¼Ò Ä§½À ¼ö¼ú·Î ÀüȯÇϰí ÀÖ½À´Ï´Ù. IMARC Group¿¡ µû¸£¸é ¼¼°è ÃÖ¼Òħ½À¼ö¼ú ½ÃÀå ±Ô¸ð´Â 2023³â 529¾ï ´Þ·¯¿¡ ´ÞÇß½À´Ï´Ù. 2024-2032³â ¿¬Æò±Õ ¼ºÀå·ü(CAGR)Àº 6%·Î 2032³â±îÁö 910¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøÇß½À´Ï´Ù. ÀÌ·¯ÇÑ ½Ã¼ú¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡´Â ȯÀÚÀÇ È¥¶õÀ» ÃÖ¼ÒÈ­Çϸ鼭 »ð°ü Áß Á¤È®ÇÑ Á¦¾î¿Í ½Ã°¢È­¸¦ Á¦°øÇÏ´Â ºñµð¿À ÈĵΰæÀÇ »ç¿ë°ú ÀÏÄ¡ÇÕ´Ï´Ù. ÀÌ·¯ÇÑ ¿äÀεéÀº ÇâÈÄ ¼ö³â°£ ¸¶Ãë¿ë ºñµð¿À ÈÄµÎ°æ ½ÃÀåÀ» ÃËÁøÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

È£Èí±â Áúȯ ¹ß»ý·ü Áõ°¡

¸¸¼ºÆó¼â¼ºÆóÁúȯ(COPD), õ½Ä, Æó¼â¼º¼ö¸é¹«È£ÈíÁõÈıº(OSA) µî È£Èí±â ÁúȯÀÇ À¯º´·üÀÌ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ¿¹¸¦ µé¾î ¹Ì±¹ ÆóÇùȸ¿¡ µû¸£¸é 2022³â¿¡´Â ¼ºÀÎÀÇ 4.6%¿¡ ÇØ´çÇÏ´Â 1,100¸¸ ¸í ÀÌ»óÀÌ COPD(¸¸¼ºÆó¼â¼ºÆóÁúȯ, ¸¸¼º±â°üÁö¿°, Æó±âÁ¾)¸¦ ¾Î°í ÀÖ´Â °ÍÀ¸·Î º¸°íµÇ°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ ¼¼°èº¸°Ç±â±¸(WHO)°¡ ¹ßÇ¥ÇÑ ¶Ç ´Ù¸¥ ³í¹®¿¡ µû¸£¸é 2019³â¿¡´Â ¾à 2¾ï 6,200¸¸ ¸íÀÌ Ãµ½Ä¿¡ °É·Á ¾à 455¸¸ ¸íÀÇ ¸ñ¼ûÀ» ¾Ñ¾Æ°£ °ÍÀ¸·Î ÃßÁ¤µË´Ï´Ù. ÀÌ·¯ÇÑ ÁúȯÀº Á¾Á¾ ÷´Ü ±âµµ °ü¸®°¡ ÇÊ¿äÇϹǷΠºñµð¿À Èĵΰ濡 ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ¿äÀεéÀº ¸¶Ãë¿ë ºñµð¿À ÈÄµÎ°æ ½ÃÀå ¿¹Ãø¿¡ ´õ¿í ±àÁ¤ÀûÀÎ ¿µÇâÀ» ¹ÌÄ¡°í ÀÖ½À´Ï´Ù.

±â¼ú ¹ßÀü

Ä«¸Þ¶ó ÇØ»óµµ, ±¤¿ø, ½Ã°¢È­ ±â¼úÀÇ °³¼±À» Æ÷ÇÔÇÑ ºñµð¿À ÈÄµÎ°æ ±â¼úÀÇ Çõ½ÅÀ¸·Î ÀÌ·¯ÇÑ Àåºñ´Â ´õ¿í È¿°úÀûÀÌ°í »ç¿ëÀÚ Ä£È­ÀûÀÔ´Ï´Ù. Çâ»óµÈ ½Ã°¢È­´Â ´õ ³ªÀº ±âµµ °ü¸®¸¦ µ½°í »ð°ü Áß ÇÕº´Áõ ¹ß»ý °¡´É¼ºÀ» ÁÙ¿©ÁÝ´Ï´Ù. ¿¹¸¦ µé¾î 2018³â 2¿ù Dilon Technologies Inc.´Â CoPilot VL+¸¦ ½ÃÀå¿¡ Ãâ½ÃÇß½À´Ï´Ù. ¼ö»ó °æ·Â¿¡ ºû³ª´Â Çõ½ÅÀûÀÎ ±â¼ú·Î, ÀÇ·áÁøÀÌ È£Èí°üÀ» »ðÀÔÇÒ ¶§ ±âµµÀÇ ÃÖ»óÀÇ À̹ÌÁö¸¦ ¾òÀ» ¼ö ÀÖµµ·Ï ¼³°èµÇ¾î ¸¶Ãë¿ë ºñµð¿À ÈÄµÎ°æ ½ÃÀåÀÇ ¸ÅÃâÀ» °ßÀÎÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

¸ñÂ÷

Á¦1Àå ¼­¹®

Á¦2Àå Á¶»ç ¹üÀ§¿Í Á¶»ç ¹æ¹ý

  • Á¶»çÀÇ ¸ñÀû
  • ÀÌÇØ°ü°èÀÚ
  • µ¥ÀÌÅÍ ¼Ò½º
    • 1Â÷ Á¤º¸
    • 2Â÷ Á¤º¸
  • ½ÃÀå ÃßÁ¤
    • º¸ÅÒ¾÷ ¾îÇÁ·ÎÄ¡
    • Åé´Ù¿î ¾îÇÁ·ÎÄ¡
  • Á¶»ç ¹æ¹ý

Á¦3Àå °³¿ä

Á¦4Àå ¼­·Ð

Á¦5Àå ¼¼°èÀÇ ¸¶Ãë¿ë ºñµð¿À ÈÄµÎ°æ ½ÃÀå

  • ½ÃÀå °³¿ä
  • ½ÃÀå ½ÇÀû
  • COVID-19ÀÇ ¿µÇâ
  • ½ÃÀå ¿¹Ãø

Á¦6Àå ½ÃÀå ³»¿ª : Á¦Ç°º°

  • °æ¼º Èĵΰæ
  • °æºñ¼º ¿¬¼º Èĵΰæ

Á¦7Àå ½ÃÀå ³»¿ª : ºí·¹À̵å À¯Çüº°

  • ä³Î ºí·¹À̵å Èĵΰæ
  • ºñä³Î ºí·¹À̵å Èĵΰæ

Á¦8Àå ½ÃÀå ³»¿ª : ÃÖÁ¾»ç¿ëÀÚº°

  • º´¿ø
  • ÁýÁßÄ¡·á ¼¾ÅÍ
  • ±âŸ

Á¦9Àå ½ÃÀå ³»¿ª : Áö¿ªº°

  • ºÏ¹Ì
    • ¹Ì±¹
    • ij³ª´Ù
  • ¾Æ½Ã¾ÆÅÂÆò¾ç
    • Áß±¹
    • ÀϺ»
    • Àεµ
    • Çѱ¹
    • È£ÁÖ
    • Àεµ³×½Ã¾Æ
    • ±âŸ
  • À¯·´
    • µ¶ÀÏ
    • ÇÁ¶û½º
    • ¿µ±¹
    • ÀÌÅ»¸®¾Æ
    • ½ºÆäÀÎ
    • ·¯½Ã¾Æ
    • ±âŸ
  • ¶óƾ¾Æ¸Þ¸®Ä«
    • ºê¶óÁú
    • ¸ß½ÃÄÚ
    • ±âŸ
  • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«

Á¦10Àå SWOT ºÐ¼®

Á¦11Àå ¹ë·ùüÀÎ ºÐ¼®

Á¦12Àå Porter's Five Forces ºÐ¼®

Á¦13Àå °¡°Ý ºÐ¼®

Á¦14Àå °æÀï ±¸µµ

  • ½ÃÀå ±¸Á¶
  • ÁÖ¿ä ±â¾÷
  • ÁÖ¿ä ±â¾÷ÀÇ °³¿ä
    • Ambu A/S
    • ATMOS MedizinTechnik GmbH & Co. KG
    • BOMImed Inc.
    • Clarus Medical LLC
    • Daiken Medical Co Ltd.
    • KARL STORZ SE & Co. KG
    • Medtronic Plc
    • Olympus Corporation
    • Orlvision GmbH
    • Prosurg Inc.
    • Teleflex Incorporated
    • Velosal Medical Incorporated
    • Verathon Inc.(Roper Technologies)
    • XION GmbH(Henke-Sass, Wolf GmbH)
KSA 25.09.10

The global anesthesia video laryngoscope market size reached USD 212.4 Million in 2024. Looking forward, IMARC Group expects the market to reach USD 337.8 Million by 2033, exhibiting a growth rate (CAGR) of 5.03% during 2025-2033. The surging demand for minimally invasive procedures, ongoing technological advancements, rising geriatric population, and the increasing healthcare investments are driving the market's growth.

Anesthesia Video Laryngoscope Market Trends:

Rising Trend for Minimally Invasive Procedures

The healthcare industry is shifting towards minimally invasive procedures. For instance, according to IMARC, the global minimally invasive surgery market size reached US$ 52.9 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 91.0 Billion by 2032, exhibiting a growth rate (CAGR) of 6% during 2024-2032. The growing demand for such procedures aligns with the use of video laryngoscopes, which offer precise control and visualization during intubation with minimal patient disruption. These factors are expected to propel the anesthesia video laryngoscope market in the coming years.

Increasing Incidence of Respiratory Diseases

The prevalence of respiratory conditions such as chronic obstructive pulmonary disease (COPD), asthma, and obstructive sleep apnea (OSA) is increasing. For instance, according to the American Lung Association, in 2022, more than 11 million people, or 4.6% of adults, reported having COPD (chronic obstructive lung disease, chronic bronchitis, or emphysema). Also, according to another article published by the World Health Organization (WHO), in 2019, an estimated 262 million individuals were affected by asthma, which claimed around 4,55,000 lives. These conditions often require advanced airway management, boosting the demand for video laryngoscopes. These factors are further positively influencing the anesthesia video laryngoscope market forecast.

Technological Advancements

Innovations in video laryngoscopy technology, including improvements in camera resolution, light sources, and visualization techniques, have made these devices more effective and user-friendly. Enhanced visualization helps in better airway management and reduces the likelihood of complications during intubation. For example, in February 2018, Dilon Technologies Inc. launched CoPilot VL+ onto the market. It is an innovative and award-winning technology designed to assist healthcare providers in obtaining the best possible image of the airway when inserting breathing tubes, thereby boosting the anesthesia video laryngoscope market revenue.

Global Anesthesia Video Laryngoscope Industry Segmentation:

Breakup by Product:

  • Rigid Laryngoscope
  • Transnasal Flexible Laryngoscope

According to the anesthesia video laryngoscope market outlook, rigid laryngoscopes have a solid, straight, or slightly curved blade that is used to lift the tongue and epiglottis to visualize the vocal cords and facilitate intubation. While a transnasal flexible larynoscope is designed to be inserted through the nasal passage. It has a flexible, thin scope that can navigate the nasal and pharyngeal anatomy to visualize the larynx and vocal cords.

Breakup by Blade Type:

  • Channelled Blade Laryngoscope
  • Non- Channelled Blade Laryngoscope

According to the anesthesia video laryngoscope market overview, the channelled blade allows for the simultaneous insertion of the endotracheal tube and other tools, making it particularly valuable in emergency scenarios where rapid intubation is crucial. While non-channelled laryngoscopes are generally less expensive, making them a cost-effective choice for routine intubation procedures in various clinical settings. In settings where high volumes of intubations are performed, such as in general hospitals or surgical centers, non-channelled laryngoscopes are widely used due to their effectiveness and lower cost.

Breakup by End User:

  • Hospitals
  • Critical Care Centers
  • Others

Video laryngoscopes provide a clear, real-time view of the airway, which helps in the accurate placement of endotracheal tubes and reduces the risk of intubation-related complications. Moreover, hospitals encounter a range of cases, including those with challenging airways. Video laryngoscopes are particularly beneficial in such scenarios by offering enhanced visualization and increasing success rates. While in critical care settings, such as ICU and emergency departments, quick and effective airway management is essential. Video laryngoscopes facilitate rapid and accurate intubation, which is vital in emergencies.

Breakup by Region:

  • North America
    • United States
    • Canada
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa

The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia and others); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa.

According to the anesthesia video laryngoscope market statistics, the high adoption rate of advanced medical technologies due to the presence of well-established healthcare infrastructure and significant investments in innovation are driving the market's growth in North America. Moreover, strong healthcare infrastructure and high standards of medical care in Europe lead to widespread adoption of advanced medical technologies, including video laryngoscopes.

Competitive Landscape:

The market research report has provided a comprehensive analysis of the competitive landscape. Detailed profiles of all major market companies have also been provided. Some of the key players in the market include:

  • Ambu A/S
  • ATMOS MedizinTechnik GmbH & Co. KG
  • BOMImed Inc.
  • Clarus Medical LLC
  • Daiken Medical Co Ltd.
  • KARL STORZ SE & Co. KG
  • Medtronic Plc
  • Olympus Corporation
  • Orlvision GmbH
  • Prosurg Inc.
  • Teleflex Incorporated
  • Velosal Medical Incorporated
  • Verathon Inc. (Roper Technologies)
  • XION GmbH (Henke-Sass, Wolf GmbH)

Key Questions Answered in This Report:

  • How has the global anesthesia video laryngoscope market performed so far and how will it perform in the coming years?
  • What are the key regional markets?
  • What has been the impact of COVID-19 on the global anesthesia video laryngoscope market?
  • What is the breakup of the market based on the product?
  • What is the breakup of the market based on the blade type?
  • What is the breakup of the market based on the end user?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global anesthesia video laryngoscope market and who are the key players?
  • What is the degree of competition in the industry?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Anesthesia Video Laryngoscope Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product

  • 6.1 Rigid Laryngoscope
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Transnasal Flexible Laryngoscope
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast

7 Market Breakup by Blade Type

  • 7.1 Channelled Blade Laryngoscope
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Non-Channelled Blade Laryngoscope
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast

8 Market Breakup by End User

  • 8.1 Hospitals
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Critical Care Centers
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Others
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Ambu A/S
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 Financials
      • 14.3.1.4 SWOT Analysis
    • 14.3.1 ATMOS MedizinTechnik GmbH & Co. KG
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
    • 14.3.2 BOMImed Inc.
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
    • 14.3.3 Clarus Medical LLC
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
    • 14.3.4 Daiken Medical Co Ltd.
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 Financials
    • 14.3.5 KARL STORZ SE & Co. KG
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
      • 14.3.5.3 Financials
      • 14.3.5.4 SWOT Analysis
    • 14.3.6 Medtronic Plc
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
    • 14.3.7 Olympus Corporation
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 Financials
      • 14.3.7.4 SWOT Analysis
    • 14.3.8 Orlvision GmbH
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
      • 14.3.8.3 Financials
    • 14.3.9 Prosurg Inc.
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
    • 14.3.10 Teleflex Incorporated
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
      • 14.3.10.3 Financials
      • 14.3.10.4 SWOT Analysis
    • 14.3.11 Velosal Medical Incorporated
      • 14.3.11.1 Company Overview
      • 14.3.11.2 Product Portfolio
    • 14.3.12 Verathon Inc. (Roper Technologies)
      • 14.3.12.1 Company Overview
      • 14.3.12.2 Product Portfolio
      • 14.3.12.3 SWOT Analysis
    • 14.3.13 XION GmbH (Henke-Sass, Wolf GmbH)
      • 14.3.13.1 Company Overview
      • 14.3.13.2 Product Portfolio
      • 14.3.13.3 Financials
»ùÇà ¿äû ¸ñ·Ï
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
¸ñ·Ï º¸±â
Àüü»èÁ¦